NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

That is irrelevant, the initial introduction footnotes to Dr. Liau’s work on DCVax-L, including the interim results publication and the publication of the final Phase 3 results in JAMA Onc. NWBO is not a sponsor but her work on the vaccine is cumulative, and over time. The notion that she starts every test effort and variation with an entirely new vaccine despite getting great and intended results with the vaccine they started with is a bizarre notion that only shorts would suggest as if it were a serious discussion point.

The UCLA work stream is determined, focused and scientifically rational, not fickle and nonsensical, as shorts would constantly suggest.